WESPAC Advisors’s Astera Labs ALAB Stock Holding History

WESPAC Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,317	Closed	-$219K	–	211
2025 Q4	$219K	Sell	1,317 -391	-23%	-$65.4K	0.12%	159
2025 Q3	$334K	Buy	+1,708	New	+$281K	0.2%	137

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

WESPAC Advisors's ALAB Position: Q1 2026 in Review

WESPAC Advisors sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 1,317 shares — an estimated $219K sold.

WESPAC Advisors first reported a position in ALAB in Q3 2025 and held it in 2 quarters. The position peaked at $334K in Q3 2025. 706 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

WESPAC Advisors reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
WESPAC Advisors sold 1,317 Astera Labs shares in Q1 2026, an estimated $219K.
WESPAC Advisors first reported a position in Astera Labs in Q3 2025 and held it in 2 quarters.
WESPAC Advisors's Astera Labs position peaked at $334K in Q3 2025.
706 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on WESPAC Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.